DEVELOPMENT OF BUCCAL MUCOADHESIVE FILM FOR RAPID DELIVERY OF NARATRIPTAN
DOI:
https://doi.org/10.22159/ijpps.2025v17i11.56075Keywords:
Buccal patch, Buccal delivery system, Naratriptan, Natural and synthetic polymers, Solvent casting technique, Diffusion mechanismAbstract
Objective: To prepare matrix-type buccal therapeutic systems of naratriptan using various polymers as matrix formers. Formulated buccal films were characterized for physicochemical properties.
Methods: Naratriptan mucoadhesive buccal films were developed by using solvent casting method (evaluation parameters are film uniformity and thickness, weight variation, moisture content, folding endurance) and by direct milling method (drug content uniformity, swelling behavior, in vitro release studies, stability studies).
Results: Results revealed that prepared patches showed good physical characteristics, no drug-polymer interaction was observed. The in vitro release study revealed that F1 formulation showed maximum release of 94.62% in 8 h. The absorption maxima of naratriptan is at 275 nm. The predominant release mechanism of drug through the fabricated matrices was believed to be by diffusion mechanism and the percentage drug release was found to be decreasing from 94.62% to 91.20%.
Conclusion: Based upon the in vitro dissolution data the F1 formulation was concluded as optimized formulation.
Downloads
References
1.Salehi S., Boddohi S. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate. Prog Biomater. 2017;6:175–187.
2.Sang-Chul Shin, Jin-Pil Bum, Jun-Shik Choi. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bio-adhesive gels in rabbits.Int J Pharm. 2009; 209:37-43.
3.Giradkar MA, Channawar AD, Kajale E, Sridhar RS, Kamble BV, Chandewar. Design, development and in vitro evaluation of bioadhesive dosage form for buccal route. Int J Pharm Res Dev. 2010; 2(6):1-20.
4.Rajashree Mashru,Vijay Sutariya, Mayur Sankalia, Jolly Sankalia.Transbuccal delivery of lamotrigine across procine buccal mucosa in vitro determination of routes of buccal transport. J Pharm Pharmaceut Sci. 2005; 8:54-62.
5.Miller NS, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Advanced Drug Delivery Reviews. 2005;57:1666–91.
6.Begum, M.Yasmin, Alqahtani, Ali, Ghazwani, Mohammed et al. Preparation of Carbopol 934 Based Ketorolac Tromethamine Buccal Mucoadhesive Film: In Vitro, Ex Vivo, and In Vivo Assessments.Int J Polym Sci. 2021;11.
7.Pramodkumar TM et al. Oral transmucosal drug delivery systems.Indian drug. 2004;41(2):63-1.
8.Yajaman S., Bandyopadhyay AK. Buccal bioadhesive drug delivery- A promising option for orally less efficient drugs. J Controlled Release. 2006; 114:15–40.
9.Sudhakar Y, Knotsu K, Bandopadhyay AK. Bio adhesive drug delivery – A promising option for orally less efficient drugs. J Control Rel. 2006; 114:15-40.
10.Dixit, G. R., et al.Formulation and characterization of mucoadhesive buccal film of ranitidine hydrochloride using sterculiafoetida gum as polymer. Asian J Pharm Clin Res. 2015;8(3): 68-71.
11.Yelave,Adesh,Geetabhagwat.Mucoadhesive buccal films:a novel approach for the delivery of anti-hypertensive drugs.Asian J Pharm Clin Res. 2021;14(4):12-21.
12.Nishan N. Bobade et al.A Review on Buccal Drug Delivery System.Int J Pharm and Pharm Sci Res. 2013; 3(1): 35-40.
13.Miller NS, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery.Adv drug deli rev. 2005;4(2):1666-1691.
14.Dixit R.P., Puthli S.P.Oral strip technology: Overview and future potential.Journal of Controlled Release. 2009;139:94–107.
15.Khobragade PK, Puranik PK, Suradkhar SS.Literature studies on preparation and evaluation of buccal patches.Int J Pharm Rev Res. 2014; 25(2):83-91.
16.G. D.,Sindhu,et al.Buccalmucoadhesivefilms.Int J Curr Pharm Res. 2021;13(4): 14-20.
17.Gawas S, Dev A, Deshmukh G, Rathod S.Current approaches in buccal drug delivery system. Pharmaceutical and Biological Evaluations. 2016;3(2): 165-7.
18.Patel R, Shardul N, Patel J, Baria.An overview on buccal mucoadhesive films. Arch Pharm Sci & Res. 2009;1(2):212-7.
19.Amir H, et al. Systemic drug delivery via the buccal mucosal route.Pharmaceutical technology. 2001,1- 27.
20.Apoorva M, Neha C, Geeta A. Formulation and characterization of fast dissolving buccal films: A review.Der Pharmacia Lettre. 2011;3(1):152-65.
21.Gandhi RB,Robinson JR.Oral cavity as a site for bioadhesive drug delivery.Adv drug Del Rev. 1994;13:43-74.
22.Prakash,Soni,Paswan,Saini,et al.Formulation and optimization of mucoadhesive buccal film for nicotine replacement therapy.Int J Appl Pharm. 2023;15(3):100–112.
23.Nair AB, Shah J, Jacob S, Al-Dhubiab BE, Patel V, Sreeharsha N,et al. Development of Mucoadhesive Buccal Film for Rizatriptan: In Vitro and In Vivo Evaluation. Pharmaceutics. 2021;13(5):728.
24.Muthamil C., Sreedharan N.K., Senthilkumar K.L.Formulation And Evaluation Of Mucoadhesive Film For The Treatment Of Migraine.Int. J. of Pharm. Sci. 2024;2(5):660-672.
25.Nair AB, Al-Dhubiab BE, Shah J, Jacob S, Saraiya V, Attimarad M,et al.Mucoadhesive buccal film of almotriptan improved therapeutic delivery in rabbit model. Saudi Pharm J. 2020;28(2):201-209.
26.Bhikshapathi,V.Durga madhuri,V. Rajesham,R.Preparation and evaluation of fast dissolving oral film containing Naratriptan HCl.Am J Pharm Tech Res. 2014;4(2):799-812.
Published
How to Cite
Issue
Section
Copyright (c) 2025 MANTHASA, FARHEEN FAZEELAT, ALVIA ANJUM
This work is licensed under a Creative Commons Attribution 4.0 International License.
